Picture of Medincell SA logo

MEDCL Medincell SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Medincell H1 Revenues EUR 11.6 Mln

Dec 9 (Reuters) - Medincell SA MEDCL.PA:

PUBLISHES ITS CONSOLIDATED HALF-YEAR FINANCIAL RESULTS

H1 REVENUES EUR 11.6 MILLION, UP 35% YOY

H1 TOTAL INCOME EUR 14.1 MILLION, UP 50% YOY

H1 OPERATING EXPENSES EUR 20.8 MILLION, UP 22% YOY

NEW DRUG APPLICATION SUBMITTED BY TEVA TO FDA FOR OLANZAPINE LAI ON DECEMBER 9, 2025

Source text: ID:nBw4qgkhsa

Further company coverage: MEDCL.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Medincell SA

See all news